MAXIM PHARMACEUTICALS INC
SC 13G, 1999-08-02
MEDICINAL CHEMICALS & BOTANICAL PRODUCTS
Previous: APPLIED ANALYTICAL INDUSTRIES INC, 8-K, 1999-08-02
Next: SBI COMMUNICATIONS INC, 10KSB40, 1999-08-02



<PAGE>

CUSIP NUMBER:  57772M107                                       PAGE 1 OF 9 PAGES



                       SECURITIES AND EXCHANGE COMMISSION
                             WASHINGTON, D.C. 20549

                                  SCHEDULE 13G

             INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT
           TO RULE 13d-1(b), (c) AND (d) AND AMENDMENTS THERETO FILED
                            PURSUANT TO RULE 13d-2(b)
                             (Amendment No. _____)*

                           MAXIM PHARMACEUTICALS, INC.
                           ---------------------------
                                (Name of Issuer)

                          Common Stock, $.001 Par Value
                          -----------------------------
                         (Title of Class of Securities)

                                    57772M107
                                    ---------
                                 (CUSIP Number)


                                Gary S. Kaminsky
                     c/o Rose Glen Capital Management, L.P.
                               251 St. Asaphs Rd.
                               3 Bala Plaza - East
                              Bala Cynwyd, PA 19004
                              ---------------------
                       (Name, Address and Telephone Number
                         of Person Authorized to Receive
                           Notices and Communications)

                                  July 23, 1999
                                  -------------
                      (Date of Event which Requires Filing
                               of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule
is filed:

         |_|  Rule 13d-1(b)
         |X|  Rule 13d-1(c)
         |_|  Rule 13d-1(d)


*The remainder of this cover page shall be filled out for a reporting person's
initial filing on this form with respect to the subject class of securities, and
for any subsequent amendment containing information which would alter the
disclosures provided in a prior cover page.

The information required on the remainder of this cover page shall not be deemed
to be "filed" for the purpose of Section 18 of the Securities Exchange Act of
1934 or otherwise subject to the liabilities of that section of the Act but
shall be subject to all other provisions of the Act.





<PAGE>

CUSIP NUMBER:  57772M107                                       PAGE 2 OF 9 PAGES


- --------------------------------------------------------------------------------

1)       Names of Reporting Persons; S.S. or I.R.S. Identification

                  RGC International Investors, LDC
- --------------------------------------------------------------------------------

2)       Check the Appropriate Box if a Member of a Group (See Instructions)

         (a)      N/A
         (b)      N/A
- --------------------------------------------------------------------------------

3)       SEC Use Only
- --------------------------------------------------------------------------------

4)       Citizenship or Place of Organization                    Cayman Islands
- --------------------------------------------------------------------------------

   Number of                        5)      Sole Voting Power        608,480 (1)
    Shares                          --------------------------------------------
 Beneficially
   Owned by                         6)      Shared Voting Power
Each Reporting                      --------------------------------------------
 Person With
                                    7)      Sole Dispositive Power   608,480 (1)
                                    --------------------------------------------

                                    8)      Shared Dispositive Power
- --------------------------------------------------------------------------------

9)       Aggregate Amount Beneficially                               608,480 (1)
         Owned by Each Reporting Person
- --------------------------------------------------------------------------------

10)      Check if the Aggregate Amount in Row (9)
         Excludes Certain Shares (See Instructions)                          N/A
- --------------------------------------------------------------------------------

11)      Percent of Class Represented by Amount in Row (9)                  5.6%
- --------------------------------------------------------------------------------

12)      Type of Reporting Person (See Instructions)                          OO
- --------------------------------------------------------------------------------




<PAGE>

CUSIP NUMBER:  57772M107                                       PAGE 3 OF 9 PAGES


- --------------------------------------------------------------------------------

1)       Names of Reporting Persons; S.S. or I.R.S. Identification

                  Rose Glen Capital Management, L.P.
- --------------------------------------------------------------------------------

2)       Check the Appropriate Box if a Member of a Group (See Instructions)

         (a)      N/A
         (b)      N/A
- --------------------------------------------------------------------------------

3)       SEC Use Only
- --------------------------------------------------------------------------------

4)       Citizenship or Place of Organization                    Delaware
- --------------------------------------------------------------------------------

   Number of                        5)      Sole Voting Power        608,480 (1)
    Shares                          --------------------------------------------
 Beneficially
   Owned by                         6)      Shared Voting Power
Each Reporting
 Person With                        --------------------------------------------

                                    7)      Sole Dispositive Power   608,480 (1)
                                    --------------------------------------------

                                    8)      Shared Dispositive Power
- --------------------------------------------------------------------------------

9)       Aggregate Amount Beneficially                               608,480 (1)
         Owned by Each Reporting Person
- --------------------------------------------------------------------------------

10)      Check if the Aggregate Amount in Row (9)
         Excludes Certain Shares (See Instructions)                          N/A
- --------------------------------------------------------------------------------

11)      Percent of Class Represented by Amount in Row (9)                  5.6%
- --------------------------------------------------------------------------------

12)      Type of Reporting Persons (See Instructions)                         PN
- --------------------------------------------------------------------------------




<PAGE>

CUSIP NUMBER:  57772M107                                       PAGE 4 OF 9 PAGES


- --------------------------------------------------------------------------------

1)       Names of Reporting Persons; S.S. or I.R.S. Identification

                  RGC General Partner Corp.
- --------------------------------------------------------------------------------

2)       Check the Appropriate Box if a Member of a Group (See Instructions)

         (a)      N/A
         (b)      N/A
- --------------------------------------------------------------------------------

3)       SEC Use Only
- --------------------------------------------------------------------------------

4)       Citizenship or Place of Organization                         Delaware
- --------------------------------------------------------------------------------

   Number of                        5)      Sole Voting Power        608,480 (1)
    Shares                          --------------------------------------------
 Beneficially
   Owned by                         6)      Shared Voting Power
Each Reporting
 Person With                        --------------------------------------------

                                    7)      Sole Dispositive Power   608,480 (1)
                                    --------------------------------------------

                                    8)      Shared Dispositive Power
- --------------------------------------------------------------------------------

9)       Aggregate Amount Beneficially                               608,480 (1)
         Owned by Each Reporting Person
- --------------------------------------------------------------------------------

10)      Check if the Aggregate Amount in Row (9)
         Excludes Certain Shares (See Instructions)                          N/A
- --------------------------------------------------------------------------------

11)      Percent of Class Represented by Amount in Row (9)                  5.6%
- --------------------------------------------------------------------------------

12)      Type of Reporting Persons (See Instructions)                         CO
- --------------------------------------------------------------------------------




<PAGE>

CUSIP NUMBER:  57772M107                                       PAGE 5 OF 9 PAGES


                     FOOTNOTES TO COVER PAGE OF SCHEDULE 13G


1.       This Schedule 13G is being filed on behalf of the following persons
         (the "Filers"):

         (1)      RGC International Investors, LDC, a Cayman Islands limited
                  duration company ("RGC");

         (2)      Rose Glen Capital Management, L.P., a Delaware limited
                  partnership ("Rose Glen"); and

         (3)      RGC General Partner Corp., a Delaware corporation ("Partner").

         Each of Rose Glen and Partner shall be collectively referred to as
         the "RGC Affiliates."

         RGC is a private investment fund. Rose Glen is the investment manager
         of RGC and Partner is the general partner of Rose Glen. The Common
         Stock to which this Schedule 13G relates is owned by RGC. The name,
         residence or business address, principal occupation or employment and
         citizenship of each of the executive officers of the RGC Affiliates are
         set forth in the table on Schedule A hereto.

         RGC is reporting that it owns, and Rose Glen as investment manager of
         RGC and Partner as general partner of Rose Glen is reporting that they
         beneficially own, 608,480 shares of Common Stock or approximately 5.6%
         of the outstanding shares of the Issuer. The total number of shares of
         Common Stock the Filers are reporting as being beneficially owned by
         them consists of 308,480 shares of Common Stock currently issuable
         within 60 days of the date hereof upon conversion of 30,848 shares of
         Series A Convertible Preferred Stock (the "Conversion Shares") issued
         on July 23, 1999 pursuant to that certain Series A Convertible
         Preferred Stock and Warrant Purchase Agreement dated as of July 20,
         1999 among the Issuer and certain investors named therein (the
         "Securities Purchase Agreement") and 300,000 shares of Common Stock
         currently issuable within 60 days of the date hereof upon exercise of
         Common Stock Purchase Warrants issued on July 20, 1999 pursuant to the
         Securities Purchase Agreement (the "Warrants"). The Warrants are
         exercisable at an exercise price of $10.50 and expire on July 20, 2004.
         The Conversion Shares are convertible at an initial conversion price of
         $9.725. Thereafter the conversion price shall vary as set forth more
         fully in the certificate of designations.

         Each of RGC and the RGC Affiliates has sole power to vote and to
         dispose of the shares indicated.


<PAGE>



CUSIP NUMBER:  57772M107                                       PAGE 6 OF 9 PAGES


                                  SCHEDULE 13G

ITEM 1.           (a).     NAME OF ISSUER:  Maxim Pharmaceuticals, Inc. (the
                           "Issuer")

                  (b).     ADDRESS OF ISSUER'S PRINCIPAL EXECUTIVE OFFICES:
                           8899 University Center Lane, Suite 400, San Diego,
                           California 92122

ITEM 2.           (a).     NAME OF PERSON FILING:  This Schedule 13G is being
                           filed on behalf of the following persons (the
                           "Filers"):

                           (1)      RGC International Investors, LDC, a Cayman
                                    Islands limited duration company ("RGC");

                           (2)      Rose Glen Capital Management, L.P., a
                                    Delaware limited partnership ("Rose Glen");
                                    and

                           (3)      RGC General Partner Corp., a Delaware
                                    corporation ("Partner").

                           Each of Rose Glen and Partner shall be collectively
                           referred to as the "RGC Affiliates."

                           RGC is a private investment fund. Rose Glen is the
                           investment manager of RGC and Partner is the general
                           partner of Rose Glen. The Common Stock to which this
                           Schedule 13G relates is owned by RGC. The name,
                           residence or business address, principal occupation
                           or employment and citizenship of each of the
                           executive officers of the RGC Affiliates are set
                           forth in the table on Schedule A hereto.

                  (b).     ADDRESS OF PRINCIPAL BUSINESS OFFICE OR, IF NONE,
                           RESIDENCE: The business address for each of the RGC
                           Affiliates is 251 St. Asaphs Road, Suite 200, 3 Bala
                           Plaza - East, Bala Cynwyd, Pennsylvania 19004. The
                           business address for RGC is c/o SEI Fund Resources
                           International, Ltd., 30 Herbert Street, Dublin,
                           Ireland 2. The residence or business address of each
                           of the executive officers of the RGC Affiliates are
                           set forth in the table on Schedule A hereto.

                  (c).     CITIZENSHIP: RGC is a Cayman Islands limited duration
                           company. Rose Glen is a Delaware limited partnership.
                           Partner is a Delaware corporation. The citizenship of
                           each of the executive officers of the RGC Affiliates
                           are set forth in the table on Schedule A hereto.

                  (d).     TITLE OF CLASS OF SECURITIES: Common Stock, $0.001
                           par value (the "Common Stock").

                  (e).     CUSIP NUMBER:  57772M107


<PAGE>



CUSIP NUMBER:  57772M107                                       PAGE 7 OF 9 PAGES


ITEM 3.           IF THIS STATEMENT IS FILED PURSUANT TO RULE 13d-1(b), OR
                  13d-2(b) OR (c), CHECK WHETHER THE PERSON FILING IS A: N/A

                  If this statement is filed pursuant to Rule 13d-1(c), check
                  this box.      |X|

ITEM 4.           OWNERSHIP. For information concerning the ownership of
                  Common Stock of the Issuer by RGC and the RGC Affiliates, see
                  Items 5 through 9 and 11 of the cover pages to this Schedule
                  13G and the footnotes thereto.

ITEM 5.           OWNERSHIP OF FIVE PERCENT OR LESS OF A CLASS.     N/A

ITEM 6.           OWNERSHIP OF MORE THAN FIVE PERCENT ON BEHALF OF ANOTHER
                  PERSON. RGC has granted to Rose Glen, as investment manager,
                  the sole power to manage RGC's investments.

ITEM 7.           IDENTIFICATION AND CLASSIFICATION OF THE SUBSIDIARY WHICH
                  ACQUIRED THE SECURITY BEING REPORTED ON BY THE PARENT HOLDING
                  COMPANY. N/A

ITEM 8.           IDENTIFICATION AND CLASSIFICATION OF MEMBERS OF THE GROUP. N/A

ITEM 9.           NOTICE OF DISSOLUTION OF GROUP.                           N/A

ITEM 10.          CERTIFICATIONS.

                  By signing below I certify that, to the best of my knowledge
                  and belief, the securities referred to above were not acquired
                  and are not held for the purpose of or with the effect of
                  changing or influencing the control of the issuer of the
                  securities and were not acquired and are not held in
                  connection with or as a participant in any transaction having
                  that purpose or effect.








<PAGE>



CUSIP NUMBER:  57772M107                                       PAGE 8 OF 9 PAGES


                                   SIGNATURES

         After reasonable inquiry and to the best of my knowledge and belief, I
         certify that the information set forth in this statement is true,
         complete and correct.

DATED:  August 2, 1999.

                                     RGC INTERNATIONAL INVESTORS, LDC
                                     By:  Rose Glen Capital Management, L.P.
                                              By:  RGC General Partner Corp.



                                     By:  /s/ Wayne D. Bloch
                                        ---------------------------------
                                              Wayne D. Bloch
                                              Managing Director


                                     ROSE GLEN CAPITAL MANAGEMENT, L.P.
                                     By:  RGC General Partner Corp.



                                     By:  /s/ Wayne D. Bloch
                                        ---------------------------------
                                              Wayne D. Bloch
                                              Managing Director


                                     RGC GENERAL PARTNER CORP.


                                     By:  /s/ Wayne D. Bloch
                                        ---------------------------------
                                              Wayne D. Bloch
                                              Managing Director


         ATTENTION:  INTENTIONAL MISSTATEMENTS OR OMISSIONS OF FACT
         CONSTITUTE FEDERAL CRIMINAL VIOLATIONS (SEE 18 U.S.C. Section 1001)





<PAGE>



CUSIP NUMBER:  57772M107                                       PAGE 9 OF 9 PAGES

                                   SCHEDULE A


         The name, citizenship and principal occupation or employment of each
executive officer of the RGC Affiliates are set forth below. The business
address of the above listed persons is 251 St. Asaphs Road, Suite 200, 3 Bala
Plaza-East, Bala Cynwyd, Pennsylvania 19004.


<TABLE>
<CAPTION>
NAME AND POSITION        CITIZENSHIP         PRINCIPAL OCCUPATION OR EMPLOYMENT

<S>                      <C>                <C>
Wayne D. Bloch           United States       Managing Director - RGC General Partner Corp.*

Gary S. Kaminsky         United States       Managing Director - RGC General Partner Corp.*

Steven B. Katznelson     Canada              Managing Director - RGC General Partner Corp.*
</TABLE>


RGC is governed by a board of directors consisting of Messrs. Bloch, Kaminsky
and Katznelson and three additional persons who are affiliates of RGC's
administrator, SEI Fund Resources International, Ltd. RGC's board of directors
has granted to Rose Glen, as investment manager, the sole power to manage RGC's
portfolio of investments.


*        Messrs. Bloch, Kaminsky and Katznelson own all of the outstanding
         capital stock of Partner, are the sole officers and directors of
         Partner and are parties to a shareholders agreement pursuant to which
         they collectively control Partner. Through Partner, Messrs. Bloch,
         Kaminsky and Katznelson control Rose Glen.


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission